Primary Care Clinics in Delray Beach, FL Accepting Medicare
165 Primary Care Clinics found. Showing 161 - 165
 Associates Of Internal Medicine P A Internal Medicine Medicare: Medicare Enrolled Practice Location: 13660 Jog Rd, Suite 5, Delray Beach, FL 33446 Phone: 561-498-7474 Fax: 561-819-6466 |
Cesar Figueroa Md Pa General Practice Medicare: Medicare Enrolled Practice Location: 2605 W Atlantic Ave Ste D104, Delray Beach, FL 33445 Phone: 561-499-7933 Fax: 561-499-7949 |
Paul M. Schwartz Md Pa Internal Medicine Medicare: Medicare Enrolled Practice Location: 6290 Linton Blvd, Ste 102, Delray Beach, FL 33484 Phone: 561-499-4217 Fax: 561-865-4471 |
Claudia V. Perdei Md, P.a. General Practice Medicare: Medicare Enrolled Practice Location: 5258 Linton Blvd Ste 305, Delray Beach, FL 33484 Phone: 561-496-4000 Fax: 561-637-0519 |
Nutrition Coach Inc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 100 E Linton Blvd, Suite 304b, Delray Beach, FL 33483 Phone: 561-289-7215 Fax: 561-210-1374 |
News Archive
CDEX' ValiMed MVS and ID2 Meth Scanner placed on ABMI GSA Contract Schedule
CDEX Inc. and All Business Machines, Inc. announce that the ValiMed™ MVS (Medication Validation System) and ID2 Meth Scanner™ product lines by CDEX have been placed on the ABMI GSA Contract Schedule. ValiMed MVS puts a technological safety net between the patient and errors made in the compounding of high risk medications and guards against narcotic diversion. Both are now available to the Government markets through the ABMI GSA Schedule.
Study finds rapid increase in IgG and IgA antibody levels following COVID-19 mRNA vaccination
A new study describes the kinetics of the antibody response to the earliest approved vaccines against COVID-19, which were developed on an mRNA platform.
Celldex commences CDX-011 Phase 2b trial in advanced breast cancer patients expressing GPNMB
Celldex Therapeutics, Inc. today announced that the first patient has been treated in a randomized Phase 2b study of the Company's CDX-011 (glembatumumab vedotin) antibody drug conjugate in glycoprotein NMB (GPNMB) expressing advanced, refractory breast cancer patients. CDX-011 targets the protein GPNMB, which is over expressed in a variety of cancers including breast cancer, melanoma, and brain tumors.
SFU researchers trace evolution of HIV in North America
A study tracing the evolution of HIV in North America involving researchers at Simon Fraser University has found evidence that the virus is slowly adapting over time to its human hosts. However, this change is so gradual that it is unlikely to have an impact on vaccine design.
› Verified 6 days ago